Compounds > salicylamide
Page last updated: 2024-11-04

salicylamide and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted

salicylamide has been researched along with Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted in 1 studies

salamide: a major impurity of hydrochlorothiazide; structure in first source

Research Excerpts

ExcerptRelevanceReference
"A diverse collection of 40 derivatives of benzohydroxamic acid (BHAs) of various structural groups were synthesized and tested against hepatitis C virus (HCV) in full-genome replicon assay."3.79Benzohydroxamic acids as potent and selective anti-HCV agents. ( Kleymenova, AA; Kochetkov, SN; Konduktorov, KA; Kozlov, MV; Prasolov, VS; Romanova, LI; Smirnova, OA, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kozlov, MV1
Kleymenova, AA1
Romanova, LI1
Konduktorov, KA1
Smirnova, OA1
Prasolov, VS1
Kochetkov, SN1

Other Studies

1 other study available for salicylamide and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted

ArticleYear
Benzohydroxamic acids as potent and selective anti-HCV agents.
    Bioorganic & medicinal chemistry letters, 2013, Nov-01, Volume: 23, Issue:21

    Topics: Animals; Antiviral Agents; Cell Line; Genome, Viral; Hepacivirus; Hepatitis C; Humans; Hydroxamic Ac

2013